AKT1 and hepatocellular carcinoma: Furthermore, the dysregulation of glutamine metabolism impacts several downstream signaling pathways, notably mTORC1 (refs. 64,65) and mTORC2–AKT–C-MYC66, affecting cellular bioenergetics and contributing to the oncogenic processes in HCC.